REVIEW
Published on 19 Dec 2024
Biomarkers for immunotherapy resistance in non-small cell lung cancer
doi 10.3389/fonc.2024.1489977
- 198 views
- Frontiers in Oncology
- Thoracic Oncology
- Research Topics
- Biomarker-Guided Strategies in NSCLC Immunotherapy
Biomarker-Guided Strategies in NSCLC Immunotherapy
1,189
Total Downloads
4,851
Total Views and Downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 15 Nov 2024
Advancing EGFR mutation subtypes prediction in NSCLC by combining 3D pretrained ConvNeXt, radiomics, and clinical features
doi 10.3389/fonc.2024.1464555
- 406 views
ORIGINAL RESEARCH
Published on 04 Nov 2024
The causal nexus between diverse smoking statuses, potential therapeutic targets, and NSCLC: insights from Mendelian randomization and mediation analysis
doi 10.3389/fonc.2024.1438851
- 506 views
SYSTEMATIC REVIEW
Published on 11 Oct 2024
Prognostic significance of the modified Glasgow Prognostic Score in NSCLC patients undergoing immune checkpoint inhibitor therapy: a meta-analysis
doi 10.3389/fonc.2024.1449853
- 537 views
ORIGINAL RESEARCH
Published on 26 Sep 2024
PD-1 expression in tumor infiltrating lymphocytes as a prognostic marker in early-stage non-small cell lung cancer
doi 10.3389/fonc.2024.1414900
- 725 views
ORIGINAL RESEARCH
Published on 21 May 2024
Association of PD-L1 expression and clinical outcomes in ROS1 - rearranged advanced non-small cell lung cancer treated with crizotinib
doi 10.3389/fonc.2024.1405683
- 668 views
Published in
Frontiers in Oncology
- Thoracic Oncology
Impact
- 4,851Topic views
- 2,893Article views
- 1,189Article downloads